T 1609/11 (Evaluation of adjuvanted vaccines/ ALK-ABELLO) of 15.03.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T160911.20160315
- Date of decision
- 15 March 2016
- Case number
- T 1609/11
- Petition for review of
- -
- Application number
- 04739011.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- EVALUATION OF ADJUVANTED VACCINES
- Applicant name
- ALK-Abelló A/S
- Opponent name
- Novartis Vaccines and Diagnostics, Inc.
STALLERGENES SA - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- -
- Catchword
- -
- Cited cases
- G 0004/92
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.